Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitascript is a prescription dietary supplement (often classified as a medical food) developed and marketed by Blue Heron Pharmaceuticals. It is formulated as an oral tablet containing a combination of bioactive B-vitamins, specifically **l-methylfolate calcium**, **pyridoxal 5-phosphate** (the active form of Vitamin B6), and **methylcobalamin** (the active form of Vitamin B12). Vitascript is indicated for the clinical dietary management of patients with nutritional deficiencies or metabolic imbalances, particularly those associated with diabetic peripheral neuropathy or hyperhomocysteinemia. By providing vitamins in their already-active forms, the product bypasses common metabolic bottlenecks (such as MTHFR polymorphisms) to support neurotransmitter synthesis and the reduction of homocysteine levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitascript.